Response evaluation: beyond RECIST
Open Access
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 18 (suppl_9), ix29-ix32
- https://doi.org/10.1093/annonc/mdm290
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Measures of Response: RECIST, WHO, and New AlternativesJournal of Clinical Oncology, 2006
- RECIST revisited: A review of validation studies on tumour assessmentEuropean Journal Of Cancer, 2006
- Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory ApprovalClinical Cancer Research, 2005
- A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment responseJournal of Clinical Epidemiology, 2005
- Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsThe British Journal of Radiology, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials.Journal of Clinical Oncology, 1989
- Criteria of tumor response used in clinical trials of chemotherapy.Journal of Clinical Oncology, 1985
- Reporting results of cancer treatmentCancer, 1981